Skip to main content
CON
NYSE Life Sciences

Concentra Raises FY26 Guidance, Declares Cash Dividend After Strong Q1

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
8
Price
$25
Mkt Cap
$3.033B
52W Low
$18.545
52W High
$24.685
Market data snapshot near publication time

summarizeSummary

Concentra Group Holdings Parent, Inc. announced its first-quarter results for the period ended March 31, 2026, alongside a declaration of a cash dividend and a significant upward revision to its full-year 2026 guidance. This positive update follows the company's strong 2025 performance and initial 2026 outlook provided in February. The raised guidance signals management's increased confidence in future performance, likely driven by strong operational results in Q1. The initiation of a cash dividend further underscores the company's robust financial health and commitment to shareholder returns. Traders will view the raised guidance and dividend as strong catalysts, potentially driving the stock higher, especially given its current proximity to its 52-week high. Investors will now watch for the detailed Q1 financials and any further commentary on the drivers behind the improved outlook.

At the time of this announcement, CON was trading at $25.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $3B. The 52-week trading range was $18.55 to $24.69. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed CON - Latest Insights

CON
May 07, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
CON
Feb 26, 2026, 5:20 PM EST
Filing Type: 10-K
Importance Score:
8
CON
Feb 26, 2026, 4:37 PM EST
Filing Type: 8-K
Importance Score:
8
CON
Jan 28, 2026, 4:54 PM EST
Filing Type: 8-K
Importance Score:
8
CON
Jan 12, 2026, 9:01 AM EST
Filing Type: 8-K
Importance Score:
8